AIM: To evaluate associations between total serum GGT activity, metabolic risk factors and prevalent metabolic disease in MESA. PATIENTS & METHODS: Continuous associations between GGT and fasting blood glucose (FBG), fasting insulin, HbA1c and Homeostasis Model Assessment Index of Insulin Resistance (HOMA-IR) were evaluated in the entire MESA cohort and in metabolic disease subgroups using linear regression models incrementally adjusted for age, gender, site, race, lifestyle, traditional risk factors and medications. Cross-sectional odds of prevalent impaired FBG, metabolic syndrome and Type 2 diabetes were calculated for GGT quintiles in the entire cohort and in subgroups defined by age (< or ≥65 years) and ethnicity. RESULTS: In multivariable models, significant associations were present between GGT activity and FBG, fasting insulin, HbA1c and HOMA-IR, with the interaction between GGT and BMI affecting the association between GGT and HOMA-IR as well as the association between BMI and HOMA-IR (p < 0.0001). Adjusted odds ratios (95% CIs) of prevalent impaired FBG, metabolic syndrome and Type 2 diabetes for quintile 5 versus 1 in the entire cohort were 2.4 (1.7-3.5), 3.3 (2.5-4.5) and 2.8 (1.8-4.4), respectively (p < 0.0001). GGT associations weakened with age. The significance of linear trends for increased prevalent metabolic disease by increasing GGT quintile varied by ethnicity. CONCLUSION: GGT is strongly associated with both cardiovascular and metabolic risk factors, including prevalent metabolic disease, in the MESA cohort.
AIM: To evaluate associations between total serum GGT activity, metabolic risk factors and prevalent metabolic disease in MESA. PATIENTS & METHODS: Continuous associations between GGT and fasting blood glucose (FBG), fasting insulin, HbA1c and Homeostasis Model Assessment Index of Insulin Resistance (HOMA-IR) were evaluated in the entire MESA cohort and in metabolic disease subgroups using linear regression models incrementally adjusted for age, gender, site, race, lifestyle, traditional risk factors and medications. Cross-sectional odds of prevalent impaired FBG, metabolic syndrome and Type 2 diabetes were calculated for GGT quintiles in the entire cohort and in subgroups defined by age (< or ≥65 years) and ethnicity. RESULTS: In multivariable models, significant associations were present between GGT activity and FBG, fasting insulin, HbA1c and HOMA-IR, with the interaction between GGT and BMI affecting the association between GGT and HOMA-IR as well as the association between BMI and HOMA-IR (p < 0.0001). Adjusted odds ratios (95% CIs) of prevalent impaired FBG, metabolic syndrome and Type 2 diabetes for quintile 5 versus 1 in the entire cohort were 2.4 (1.7-3.5), 3.3 (2.5-4.5) and 2.8 (1.8-4.4), respectively (p < 0.0001). GGT associations weakened with age. The significance of linear trends for increased prevalent metabolic disease by increasing GGT quintile varied by ethnicity. CONCLUSION: GGT is strongly associated with both cardiovascular and metabolic risk factors, including prevalent metabolic disease, in the MESA cohort.
Authors: Y Will; K A Fischer; R A Horton; R S Kaetzel; M K Brown; O Hedstrom; M W Lieberman; D J Reed Journal: Hepatology Date: 2000-10 Impact factor: 17.425
Authors: Abigail Fraser; Ross Harris; Naveed Sattar; Shah Ebrahim; George Davey Smith; Debbie A Lawlor Journal: Diabetes Care Date: 2009-01-08 Impact factor: 17.152
Authors: Kwok-Leung Ong; Robyn L McClelland; Matthew A Allison; John Kokkinos; Ben J Wu; Philip J Barter; Kerry-Anne Rye Journal: Atherosclerosis Date: 2018-10-17 Impact factor: 5.162
Authors: Tracey G Simon; Maria Esther Perez Trejo; Robyn McClelland; Ryan Bradley; Michael J Blaha; Irfan Zeb; Kathleen E Corey; Matthew J Budoff; Raymond T Chung Journal: Int J Cardiol Date: 2018-05-15 Impact factor: 4.164
Authors: Otto A Sanchez; Mariana Lazo-Elizondo; Irfan Zeb; Russell P Tracy; Ryan Bradley; Daniel A Duprez; Hossein Bahrami; Carmen A Peralta; Lori B Daniels; João A Lima; Alan Maisel; David R Jacobs; Mathew J Budoff Journal: Metabolism Date: 2016-02-27 Impact factor: 8.694
Authors: Ryan D Bradley; Annette L Fitzpatrick; David R Jacobs; Duk-Hee Lee; Nancy Swords Jenny; David Herrington Journal: Atherosclerosis Date: 2014-01-21 Impact factor: 5.162
Authors: Tracey G Simon; Maria Esther Perez Trejo; Irfan Zeb; Alexis C Frazier-Wood; Robyn L McClelland; Raymond T Chung; Matthew J Budoff Journal: Metabolism Date: 2017-06-24 Impact factor: 8.694